Fatigue and mood disorders are highly prevalent in patients with inflammatory bowel disease: A single‐centre, cross‐sectional study using patient‐reported outcomes

Documenti analoghi

• Incidence, prevalence and mortality of inflammatory bowel disease in New Zealand 2006–2022 using hospital information in the Integrated Data Infrastructure ( IDI )
  di: Angela J. Forbes, et al.
  Pubblicazione: (2025)
• 6‐Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
  di: Natalie Yu, et al.
  Pubblicazione: (2024)
• Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience
  di: Rachael Jacob, et al.
  Pubblicazione: (2024)
• Proposal and exploration of a novel score to quantify patient‐perceived burden of inflammatory bowel disease under routine care
  di: Joseph L. Pipicella, et al.
  Pubblicazione: (2025)
• Current state of the non‐pharmacological management of irritable bowel syndrome: an up‐to‐date review of the literature
  di: Rohan Patel, et al.
  Pubblicazione: (2024)